Re: My take on the timing of the PR [Correcting mis-calc...]
in response to
by
No such message found
Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Re: My take on the timing of the PR [Correcting mis-calc...]
My apologies for a 'factor of 10' typo in the 10% calc - it should be about 41M, not 4.1M!!
To call a special Shareholder meeting needs 10% - i.e. representation of about 41 million shares. Can we get that level of support?
1 Recommendations
Loading...
Loading...
Feb 04, 2011 09:29AM
13
Feb 04, 2011 01:07PM
6
Feb 04, 2011 01:51PM
6
Feb 04, 2011 03:51PM
3
Feb 04, 2011 04:07PM
1
Feb 04, 2011 04:47PM
11
Feb 04, 2011 04:58PM
10
Feb 04, 2011 05:33PM
New Message
Please
login
to post a reply